Custom Search

Brand Name(s): Biocef; Keflex; Keftab

CAS nº: 15686-71-2

(sef a lex' in)


What is Cephalexin?

Cephalexin (cefalexin) is used to treat infections caused by bacteria that are susceptible to the effects of cephalexin. Common infections that are treated with cephalexin include infections of the middle ear, tonsils, throat, larynx (laryngitis), bronchi (bronchitis) and pneumonia. It also is used for treating urinary tract, skin and bone infections.

This medication belongs to a class of antibiotics called cephalosporins. They are similar to penicillin in action and side effects. They work by stoping or slowing the growth of bacterial cells by preventing bacteria from forming in the cell wall that surrounds each cell. The cell wall protects bacteria from the external environment and keeps the contents of the cell together. Without a cell wall bacteria are not able to survive. Bacteria that are susceptible to cephalexin include Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, E. coli and several others.

It is marketed by generic pharmaceutical manufacturers under a wide range of brand names including Apo-Cephalex®, Biocef®, Cefanox®, Ceporex®, Cilex®, Keflet®, Keflex®, Keforal®, Keftab®, Keftal®, Lopilexin®, and Panixine Disperdose®.

See more Product Info

Latest News

MiddleBrook stock soars 139% over time-release antibiotic

After several years of reversals and failed trials, MiddleBrook Pharmaceuticals Inc. announced...

[more]

Antibiotics free at Martin's

Martin's Super Markets pharmacies are now offering eight generic antibiotics free with a doctor's...

[more]

Auriga and MiddleBrook to co-promote oral antiskin infection drug

Auriga Laboratories has signed a co-promotion agreement with MiddleBrook Pharmaceuticals, pursuant...

[more]

Publix offers free pills for pets

Pet owners are discovering they can get free antibiotic drugs for their four-legged friends.

[more]

Advancis Sees 2006 Keflex Sales Below Prior View

Advancis Pharmaceutical Corp. on Friday lowered its revenue estimates from its Keflex antibiotic...

[more]

Use of this site is subject to the following terms of use